Nurse Practitioner, Adult Health · San Francisco, CA
NPI
1740762343
Since 2018
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
400 Parnassus Ave
San Francisco, CA, 94143
Phone (415) 531-3291
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$396K
428 prescriptions
Company payments, 2024
$41.76
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Maritza M Lopez prescribed most often to Medicare patients was Lacosamide, with 55 prescriptions and refills. In total Maritza M Lopez wrote 428 Medicare prescriptions that cost $396K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lacosamide Generic | 55 | 77 | 12 | $5,247 |
| Clobazam Generic | 45 | 57 | 17 | $12K |
| Clonazepam Generic | 42 | 46 | 11 | $238 |
| Carbamazepine Er Carbamazepine | 26 | 26 | Under 11 | $2,823 |
| Lamotrigine Generic | 21 | 35 | Under 11 | $436 |
| Xcopri Cenobamate | 20 | 25 | Under 11 | $29K |
| Lorazepam Generic | 19 | 21 | Under 11 | $83.44 |
| Fycompa Perampanel | 16 | 16 | Under 11 | $22K |
| Levetiracetam Generic | 13 | 19 | Under 11 | $610 |
| Phenytoin Sodium Extended Generic | 13 | 23 | Under 11 | $597 |
| Banzel Rufinamide | 12 | 14 | Under 11 | $144K |
| Rufinamide Generic | 11 | 11 | Under 11 | $1,229 |
Brand drugs: 105 claims; generic drugs: 323 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Maritza M Lopez $41.76 ($41.76 in general payments such as food, travel and fees) from 1 company. The largest payer was Neurelis, Inc. with $41.76.
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 1 | $41.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.